GET DAILY SIGNALSPhilip Morris International (PM): Assessing the Path to the $220 Analyst Target
Key Takeaways
- The central target of $220 is the arithmetic mean of the verified analyst price targets that sit above the current share price, reflecting a roughly 11% move from the latest close of $197.88.
- Across all valid targets, the overall mean is about $213, with a wide low-to-high range of roughly $175 to $240, underscoring meaningful disagreement among analysts.
- Philip Morris International Inc. (PM) is a stock, not an ETF — a global consumer staples and tobacco company best known for Marlboro, IQOS, and ZYN.
- Supporting factors include strong smoke-free product momentum, solid earnings beats, dividend growth, and pricing power.
- Key risks include regulatory scrutiny of nicotine products, a premium valuation, and concentration in the smoke-free portfolio.
- For more detail on this company, visit the Major News, Today's Price Move, Forecast, and Earnings pages.
- To discover AI-driven trading tools and ideas across the market, explore Trending AI Robots.
Analyst Price Targets and Consensus View
Because the overall average of every verified analyst target fell below the 10% threshold above the current price, the $220 central target used here is calculated from only the targets above the latest close — not a headline consensus figure. For context, the full set of targets reviewed averages about $213, with a range from roughly $175 to $240. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent, firm-attributed targets illustrate how views diverge. Stifel raised its target to $232 (Nov. 3, 2026), while Goldman Sachs reiterated a Buy with a $222 target and Barclays maintained Buy at $225 (both Oct. 28, 2026). Argus Research lifted its target to $220 (Oct. 26, 2026), Morgan Stanley stood at $215, and Bank of America edged its target to $211 (Nov. 5, 2026). More cautious houses sit at the lower end: UBS holds a $201 target (Hold) and Bernstein maintains a $175 target (Hold).
Most ratings cluster around Buy, but the wide $175-to-$240 spread reflects genuine debate over how richly to value a company whose growth now depends heavily on reduced-risk products rather than traditional cigarettes.
Current Market Position and Path Toward the Target
The shares closed at $197.88 on Nov. 6, 2026, within a 52-week range of $146.35 to $214.35. Reaching $220 would require a gain of about 11%, a modest single-step move for a large-cap staple that has returned roughly 37% over the past year. PM trades near 29 times trailing EPS (earnings per share), a premium to its long-term historical multiple that raises the bar for further re-rating.
The path to $220 would likely depend less on a valuation expansion and more on continued earnings delivery: analysts model adjusted EPS rising from roughly $8.40 in fiscal 2026 toward $9.17 in 2027. Sustained smoke-free volume growth and stable combustible margins would be the clearest fundamental drivers.
What Could Support a Move Toward the Target
Philip Morris International is in the middle of a strategic shift toward smoke-free products such as IQOS heated tobacco and ZYN nicotine pouches, which now reach dozens of markets and tens of millions of users. Third-quarter 2026 revenue of about $11.44 billion and EPS of $2.20 exceeded consensus expectations, and the company has demonstrated consistent pricing power and margin discipline.
Income investors also provide a support base: the forward dividend has grown, with a current annualized payout near $6.40 per share (a yield of roughly 3.2%). Defensive cash generation, a consumer staples profile with a low beta, and the potential for a U.S. IQOS ILUMA launch pending FDA (Food and Drug Administration) authorization are recurring bullish themes in analyst notes.
What Could Prevent the Target From Being Reached
Regulation is the dominant risk. Nicotine policy, flavor restrictions, and FDA decisions on modified-risk products can shift the growth outlook quickly, and the U.S. ZYN business remains a focal point of uncertainty. A premium valuation also leaves little margin for error — if earnings momentum softens, the multiple could compress even as profits grow.
Concentration is another concern: the bull case hinges on the smoke-free transition continuing to offset cigarette volume declines in an industry where overall tobacco consumption is structurally flat to down. Any guidance trim or slower smoke-free adoption would likely pressure the shares and make $220 harder to reach.
Technical Levels and Market Structure
The 52-week high of $214.35 stands as the nearest major resistance zone, with the psychological $220 level just above it. A durable support band has formed near $175, aligning with the low end of the analyst range and with prior consolidation. The stock's long-term uptrend remains intact after the strong three- and five-year returns, but the recent pullback from the October highs suggests buyers are awaiting fresh catalysts before pushing through prior peaks. From what I see, the technical picture aligns closely with the fundamental setup.
Time Horizon and What Investors Should Monitor
Analyst price targets typically reflect a research horizon of about 12 months, though individual firms apply different frameworks. Investors weighing the path toward $220 should watch quarterly earnings and guidance, smoke-free shipment and user metrics, any FDA decisions on IQOS or ZYN, dividend announcements, and analyst revisions. Macroeconomic factors such as interest-rate moves and currency swings also matter, given PM's broad international footprint.
Final Assessment
Can PM reach $220? The target is reachable in principle, representing only about an 11% move and sitting just above the 52-week high. It is supported by strong smoke-free momentum, reliable earnings beats, dividend growth, and a generally bullish analyst posture. Yet it is not guaranteed: the wide $175-to-$240 range of analyst targets, the premium valuation, and persistent regulatory and concentration risks all argue for caution. The most constructive path requires continued smoke-free volume growth and stable margins, while the clearest downside would come from a guidance cut or an unfavorable regulatory development. I’m watching this closely as earnings season progresses.
Exploring AI Daily Buy/Sell Signals for Additional Context
In my own research process, I often reference Tickeron’s AI Daily Buy/Sell Signals to get a data-driven perspective on stocks like PM. This tool applies artificial intelligence to monitor thousands of securities in real time, producing Buy, Sell, or Hold signals based on technical patterns and market dynamics. It serves as a useful complement to traditional analyst targets and fundamental analysis, helping to highlight potential shifts that might otherwise be missed.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
PM in upward trend: price rose above 50-day moving average on October 05, 2026
PM moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +3.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where PM advanced for three days, in 233 of 389 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 173 of 328 cases where PM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.
Bearish Trend Analysis
The 10-day RSI Indicator for PM moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 24 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 27 of 66 cases where PM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 41%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PM as a result. In 40 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 51%.
The Moving Average Convergence Divergence Histogram (MACD) for PM turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 21 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 42%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.
PM broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 32 (best 1 - 100 worst), indicating outstanding price growth. PM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PM's P/B Ratio (-35.934) is slightly lower than the industry average of (-7.297). P/E Ratio (28.431) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (2.327) is also within normal values, averaging (3.595). Dividend Yield (0.032) settles around the average of (0.060) among similar stocks. PM's P/S Ratio (7.022) is slightly higher than the industry average of (2.780).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of cigarettes and other tobacco products
Industry Tobacco
Advertisement